Briefing

Featured article

US bill passed to restrict business with Chinese biotech companies

Also in this section

News in Numbers

Latest News

Latest Deals

Project Updates

10/10/2024 10:15:19
  • Home | Enhancing therapy adherence with prodrugs
  • Editor's letter
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Cytiva
  • Nipro
  • Laboratorios Argenol Company Insight
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Project Updates
  • Avenga Company Insight
  • Lactalis Ingredients
  • BSP Pharmaceuticals
  • AlfatestLAB
  • Alphial Company Insight
  • In Depth
  • Prodrugs and patents: Enhancing therapy adherence and reducing side effects
  • Are PBMs to blame for high drug prices in the US?
  • Into the unknown: how quickly can vaccines be developed for Disease X
  • US negotiations for first round of drugs reveal $6bn in Medicare savings
  • Emerging microbiome market – unlocking new frontiers
  • Build or buy? Key considerations for in-house manufacturing
  • BiomeBank Company Insight
  • IMP Pharmaceutical Services
  • Xylem
  • Sponsored Supplements
  • Techniconsult Firenze Company Insight
  • Pfanstiehl
  • Duoject Medical Systems Company Insight
  • Listings
  • Events
  • Excellence Awards
  • Innovation Rankings
  • Buyer's Guides
  • Zenatek Company Insight
  • BEA Technologies
  • Next issue
09/20/2024 00:00:00